ICICI Prudential US Bluechip Equity Fund - Growth - Regular Plan

Other Plans and Options
  • 1.84 %Nav, as on 26-05-2022

  • Previous Nav

  • Net Change on 26-05-2022

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Growth -9.36 -24.35 -1.14 16.90 15.72 15.77
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 -7.39 -9.26 -5.00 12.05 10.49 7.73

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Growth Jul 06, 2012 -1.14 16.90 15.72 2.20 1,934.97
Nippon India US Equity Opportunites Fund- Growth Plan- Growth Option Jul 23, 2015 -8.14 13.45 14.41 2.26 519.27
Franklin Asian Equity Fund - Growth Plan Jan 16, 2008 -23.63 5.25 4.45 2.56 296.28
Nippon India Japan Equity Fund- Growth Plan- Growth Option Aug 26, 2014 -11.33 6.38 6.00 2.28 223.15
Aditya Birla Sun Life International Equity Fund - Plan A - Growth - Regular Plan Oct 31, 2007 -3.11 11.59 11.71 2.57 124.53
Aditya Birla Sun Life International Equity Fund - Plan B - Growth - Regular Plan Oct 31, 2007 -1.37 10.46 7.99 2.56 96.71

Fund Holdings as on 30-April-2022

  • Merck & Co Inc

  • Kellogg Co.

  • Campbell Soup Co

  • Constellation Brands Inc

  • Medtronic Plc

  • Emerson Electric

  • Alphabet Inc

  • Biogen Inc

  • Gilead Sciences Inc

  • Philip Morris Intl Inc

  • Microsoft Corp

  • Zimmer Biomet Holdings Inc

  • Facebook Inc

  • Intel Corp

  • Guidewire Software Inc

  • Equifax Inc.

  • Honeywell Internation India Pvt Ltd

  • Western Union Co

  • Polaris Industries Inc.

  • Tyler Technologies Inc

  • Masco Corp.

  • Wells Fargo & Co

  • Amazon com

  • 3M Co

  • ECOLAB INC

  • Anheuser-Busch InBev

  • Salesforce.Com Inc

  • Boeing Co

  • Adobe Inc

  • TREPS

  • TERADYNE INC

  • Comcast Corp

  • Veeva Systems Inc

  • Lam Research Corporation

  • Vodafone Group Plc - SP ADR

  • Blackrock (US)

  • T. Rowe Price Associates Inc.

  • Walt Disney

  • Mercadolibre Inc

  • ServiceNow Inc.

  • Coca-Cola Co

  • Taiwan Semiconductor Mfg. Co. Ltd.

  • ETSY INC

  • Costar Group INC

  • Microchip Technology Inc.

  • KLA-Tencor corp

  • Net Current Assets

View More

  • Miscellaneous

View More

Fund Manager

  • ADRs & GDRs

  • Cash

  • Equity

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹1,934.97 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended up ₹0.77(1.84%)yesterday to ₹42.58.

Among its top 3 holdings the fund has exposure to Merck & Co Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Rohan Maru and Priyanka Khandelwal.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100